CBX4 and prostate cancer: These findings indicated that CBX4 served as a potential oncogene in prostate cancer, the down-regulation of CBX4 significantly inhibited the proliferation, invasion and migration of prostate cancer cells, which might act through the PI3K/AKT signaling pathway.